⌘K
t
PureTech Health PLC announced that Interim Chief Executive Officer Robert Lyne, Interim Board Chair Sharon Barber-Lui, and Non-Executive Directors John LaMattina and Michele Holcomb purchased ordinary shares of the company. These market transactions occurred on the London Stock Exchange between 22-23 September 2025. Robert Lyne acquired 81,051 shares at GBP 1.23, Sharon Barber-Lui bought 65,250 shares at GBP 1.24, John LaMattina purchased 59,100 shares at GBP 1.25, and Michele Holcomb acquired 29,239 shares at GBP 1.25, totalling an aggregate volume of 234,640 shares at an aggregated price of GBP 1.24 per share.
| Date | 24 Sept 2025 |
| Time | 07:00:14 |
| Category | Director/PDMR dealings |
| ID | 5270A |
PDMR DEALING NOTIFICATION
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||
|
a) |
Name |
Robert Lyne Sharon Barber-Lui John LaMattina Michele Holcomb |
|||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status |
Robert Lyne - Interim Chief Executive Officer Sharon Barber-Lui - Interim Board Chair; Non-Executive Director John LaMattina - Non-Executive Director Michele Holcomb - Non-Executive Director |
|||||||||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
|||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name |
PureTech Health plc |
|||||||||||||||
|
b) |
LEI |
213800LVPDNO2Z9T9I39 |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
|
|||||||||||||||
|
b) |
Nature of the transaction |
Purchase of shares in market |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information
|
|
|||||||||||||||
|
e) |
Date of the transaction |
22-23 September 2025 |
|||||||||||||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||||||||||||||